These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31848682)

  • 1. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
    Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
    Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the psychological burden of patients with hidradenitis suppurativa.
    Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
    Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study.
    Jørgensen AR; Yao Y; Thomsen SF; Ring HC
    Int J Dermatol; 2021 Jul; 60(7):785-791. PubMed ID: 33660281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
    Hayama K; Fujita H; Hashimoto T; Terui T;
    J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
    Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
    Johnston L; Dupuis E; Lam L; Poelman S
    J Cutan Med Surg; 2023; 27(5):487-492. PubMed ID: 37489915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
    Sartorius K; Emtestam L; Jemec GB; Lapins J
    Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study.
    Koumaki D; Rovithi E; Solia Apokidou E; Papadakis M; Katoulis A; Evangelou G
    Sci Rep; 2023 May; 13(1):7898. PubMed ID: 37193758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive Epidemiology of Hidradenitis Suppurativa in Greece: A Study of 152 Cases.
    Katoulis AC; Liakou AI; Rotsiamis N; Bonovas S; Bozi E; Rallis E; Christodoulou C; Rigopoulos D
    Skin Appendage Disord; 2017 Oct; 3(4):197-201. PubMed ID: 29177148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
    Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG
    J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Hidradenitis Suppurativa: An Update.
    Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Sampogna F; Marron SE; Zemskov SV; Abeni D; Tzellos T; Szepietowski JC; Zouboulis CC
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34204126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
    Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
    Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Work productivity and activity impairment in patients with hidradenitis suppurativa: a cross-sectional study.
    Yao Y; Jørgensen AR; Thomsen SF
    Int J Dermatol; 2020 Mar; 59(3):333-340. PubMed ID: 31736064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.
    Alavi A; Anooshirvani N; Kim WB; Coutts P; Sibbald RG
    Am J Clin Dermatol; 2015 Feb; 16(1):61-5. PubMed ID: 25432664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.